datetime,headline,summary,related,lang,source
2020-12-09 06:00:00-05:00,"West Announces First-Quarter 2021 Dividend, 2021 Share Repurchase Program and Participation in Upcoming Investor Conference","EXTON, Pa., Dec. 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2021 dividend of $0.17 per share. The…",WST,en,PR Newswire
2020-11-09 16:30:00-05:00,West Appoints Kimberly Banks MacKay as Senior Vice President General Counsel and Corporate Secretary,"EXTON, Pa., Nov. 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has appointed Kimberly Banks MacKay to serve as Senior Vice President General Counsel and Corporate Secretary,…",WST,en,PR Newswire
2020-11-09 11:00:00-05:00,"$57.7 Billion Sterile Medical Packaging Market , 2025 - Amcor, Dupont De Nemours, 3M, West Pharmaceutical Services, and Sonoco Products Dominate the Market","DUBLIN, Nov. 9, 2020 /PRNewswire/ -- The ""Sterile Medical Packaging Market by Material (Plastics, Metal, Glass, Others), Type (Thermoform Trays, Bottles, Vials & Ampoules, Blister & Clamshells, Others), Application (Surgical Instruments, Pharmaceutical, Others) - Forecast to 2025"" report…",WST,en,PR Newswire
2020-10-28 10:08:51-05:00,A 'premier growth' stock expert who's more than tripled investors' money at 2 different funds tells us about his interlocking strategies and his top picks for each,"Summary List Placement If competition in corporate America and the stock market is always fierce, Ron Zibelli makes sure his portfolios follow the law of survival of the fittest. Zibelli is the chief investment officer for growth stocks at Invesco, and for more than a decade he's run two highly successful mutual funds for the firm. The Invesco Oppenheimer Discovery Fund invests in the smallest companies , and according to Morningstar it's returned 404% to investors since he became manager in May 2006. The Invesco Discovery Mid Cap Growth Fund , which he's run since June 2007, has returned 286%. Both of those figures handily beat the broader stock market. Both funds invest heavily in tech and healthcare, with concentrations in areas like software, cloud computing, e-commerce, diagnostic testing, and medical devices, including those that treat diabetes. ""Both of these strategies reflect an investment process that's focused on identifying the premier growth companies and owning them for an extended period of time to enjoy the power of compounding,"" he told Business Insider in an exclusive interview.",WST,en,Business Insider
2020-10-28 05:00:00-05:00,West Announces Increase to Fourth-Quarter 2020 Dividend,"EXTON, Pa., Oct. 28, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a fourth-quarter 2020 dividend of $0.17 per share, a…",WST,en,PR Newswire
2020-10-24 07:48:46-05:00,West Pharmaceutical Services (NYSE:WST) Upgraded to Buy at Zacks Investment Research,"West Pharmaceutical Services (NYSE:WST) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report issued on Saturday, Zacks.com reports. The brokerage currently has a $313.00 price target on the medical instruments supplier’s stock. Zacks Investment Research‘s price objective indicates a potential upside of 11.02% from the stock’s current […]",WST,en,The Olympia Report
2020-10-24 07:12:43-05:00,"West Pharmaceutical Services (NYSE:WST) Posts Quarterly Earnings Results, Beats Estimates By $0.16 EPS","West Pharmaceutical Services (NYSE:WST) issued its earnings results on Thursday. The medical instruments supplier reported $1.15 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.99 by $0.16, MarketWatch Earnings reports. The company had revenue of $548.00 million during the quarter, compared to the consensus estimate of $510.15 million. West Pharmaceutical Services had […]",WST,en,The Olympia Report
2020-10-24 06:06:42-05:00,West Pharmaceutical Services (NYSE:WST) Issues FY 2020 Pre-Market Earnings Guidance,"West Pharmaceutical Services (NYSE:WST) updated its FY 2020 Pre-Market earnings guidance on Thursday. The company provided EPS guidance of 4.50-4.55 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.25. The company issued revenue guidance of $2.1-2.11 billion, compared to the consensus revenue estimate of $2.05 billion.West Pharmaceutical Services also updated its […]",WST,en,The Olympia Report
2020-10-22 23:26:41-05:00,Comparing Allied Security Innovations (OTCMKTS:ADSV) & West Pharmaceutical Services (OTCMKTS:WST),"West Pharmaceutical Services (NYSE:WST) and Allied Security Innovations (OTCMKTS:ADSV) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, analyst recommendations, earnings, institutional ownership and profitability. Profitability This table compares West Pharmaceutical Services and Allied Security Innovations’ net margins, return […]",WST,en,Dispatch Tribunal
2020-10-22 16:00:00-05:00,West Launches New Vial2Bag Advanced™ 20mm Admixture Device,"EXTON, Pa., Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), West Pharmaceutical Services, Inc. (West) is pleased to announce FDA 510(k) clearance and launch of its Vial2Bag Advanced™ 20mm Admixture Device. The Vial2Bag Advanced™ 20mm Admixture Device enables…",WST,en,PR Newswire
2020-10-22 07:39:17-05:00,West Pharmaceutical Services (NYSE:WST) Releases FY 2020 Pre-Market Earnings Guidance,"West Pharmaceutical Services (NYSE:WST) issued an update on its FY 2020 Pre-Market earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 4.50-4.55 for the period, compared to the Thomson Reuters consensus estimate of $4.25. The company issued revenue guidance of $2.1-2.11 billion, compared to the consensus revenue estimate of $2.05 […]",WST,en,Zolmax News
2020-10-22 05:00:00-05:00,West Announces Third-Quarter 2020 Results,"EXTON, Pa., Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance. Third-Quarter 2020 Summary (comparisons to prior-year period) Net sales of $548.0…",WST,en,PR Newswire
2020-10-20 17:22:49-05:00,Allied Security Innovations (OTCMKTS:ADSV) vs. West Pharmaceutical Services (OTCMKTS:WST) Financial Contrast,"Allied Security Innovations (OTCMKTS:ADSV) and West Pharmaceutical Services (NYSE:WST) are both industrial products companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation. Valuation and Earnings This table compares Allied Security Innovations and West Pharmaceutical Services’ […]",WST,en,Daily Political
2020-10-20 05:26:52-05:00,Critical Analysis: Allied Security Innovations (OTCMKTS:ADSV) and West Pharmaceutical Services (OTCMKTS:WST),"Allied Security Innovations (OTCMKTS:ADSV) and West Pharmaceutical Services (NYSE:WST) are both industrial products companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, valuation, institutional ownership, earnings, profitability, dividends and analyst recommendations. Institutional & Insider Ownership 92.6% of West Pharmaceutical Services shares are held by […]",WST,en, Dakota Financial News
2020-10-20 03:56:44-05:00,Contrasting West Pharmaceutical Services (NYSE:WST) and Allied Security Innovations (NYSE:ADSV),"West Pharmaceutical Services (NYSE:WST) and Allied Security Innovations (OTCMKTS:ADSV) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Insider and Institutional Ownership 92.6% of West Pharmaceutical Services shares are owned by institutional […]",WST,en, Dakota Financial News
2020-10-13 07:20:13-05:00,"The Daily Biotech Pulse: J&J Pauses Coronavirus Vaccine Studies, Voyager's Huntington's Disease Study Placed On Hold, Altimmune Vaccine Data","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 12) 10X Genomics Inc (NASDAQ: TXG ) Acceleron Pharma Inc (NASDAQ: XLRN ) Adaptive Biotechnologies Corp (NASDAQ: ADPT ) Applied Molecular Transport Inc. (NASDAQ: AMTI ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) argenx SE – ADR (NASDAQ: ARGX ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Blueprint Medicines Corp (NASDAQ: BPMC ) Calliditas Therapeutics Adr Rep 2 Ord Shs (NASDAQ: CALT ) Cardiff Oncology Inc (NASDAQ: CRDF ) CareDx Inc (NASDAQ: CDNA ) Castle Biosciences Inc (NASDAQ: CSTL ) Denali Therapeutics Inc (NASDAQ: DNLI ) Fate Therapeutics Inc (NASDAQ: FATE ) Immunovant Inc (NASDAQ: IMVT ) Insmed Incorporated (NASDAQ: INSM ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kronos Bio Inc (NASDAQ: KRON ) (went public Friday) Kura Oncology Inc (NASDAQ: KURA ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Lantern Pharma Inc.","XLRN,WST",en,Benzinga
2020-10-13 01:15:18-05:00,"Medical Packaging Market Update: Key Business Segments Spiral Up Again | Amcor Limited, West Pharmaceutical Services, Inc., 3M, AVERY DENNISON CORPORATION","Latest market study on “Global Medical Packaging Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Material (Sterilization, Tyvek, Foam, Molded Fiber, Fabrics, Plastics, Films, Adhesives, Others); Type (Containers, Pouches, Trays, Blister Packets, Clamshell Packs, Vials, Others);",WST,en,OpenPR
2020-10-07 06:30:09-05:00,"The Daily Biotech Pulse: Bristol-Myers Squibb's Lung Cancer Readout, Positive News From Masimo, Integra Lifesciences","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) 10X Genomics Inc (NASDAQ: TXG ) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) BioLife Solutions Inc (NASDAQ: BLFS ) Blueprint Medicines Corp (NASDAQ: BPMC ) CareDx Inc (NASDAQ: CDNA ) Castle Biosciences Inc (NASDAQ: CSTL ) Celldex Therapeutics, Inc. (NASDAQ: CLDX ) CTI BioPharma Corp (NASDAQ: CTIC ) CymaBay Therapeutics Inc (NASDAQ: CBAY ) Eidos Therapeutics Inc (NASDAQ: EIDX ) Fate Therapeutics Inc (NASDAQ: FATE ) Inspire Medical Systems Inc (NYSE: INSP ) InVitae Corp (NYSE: NVTA ) Kura Oncology Inc (NASDAQ: KURA ) Mirati Therapeutics Inc (NASDAQ: MRTX ) Novocure Ltd (NASDAQ: NVCR ) Pacific Biosciences of California Inc (NASDAQ: PACB ) Prelude Therapeutics Inc (NASDAQ: PRLD ) ProPhase Labs Inc (NASDAQ: PRPH ) Qiagen NV (NYSE: QGEN ) Repligen Corporation (NASDAQ: RGEN ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Turning Point Therapeutics Inc (NASDAQ: TPTX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Oct. 6) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) (reacted to negative results for a mid-stage study of lenabasum in cystic fibrosis patients) Dyne Therapeutics Inc (NASDAQ: DYN ) Outset Medical Inc (NASDAQ: OM ) Teligent Inc (NASDAQ: TLGT ) Stocks In Focus Integra LifeSciences' Preliminary Q3 Revenues Exceed Estimate Medtech company Integra Lifesciences Holdings Corp (NASDAQ: IART ) preannounced third-quarter results, expecting revenues of $368 million to $370 million, down about 2.7%, but exceeding the company's guidance provided at …",WST,en,Benzinga
2020-10-06 08:28:10-05:00,"Pharmaceutical Analytical Testing Outsourcing Market 2020 Global Industry Size, Growth, Segments with COVID-19 Impact Analysis || Charles River, Boston Analytical, West Pharmaceutical Services, Dalton Pharma Services, Ajinomoto Bio-Pharma","When globalization is growing day by day, many businesses call for global market research consisting of actionable market insights that helps with decision making. This Pharmaceutical Analytical Testing Outsourcing Market analysis report gives out the data for industry about company",WST,en,OpenPR
2020-09-18 12:30:00-05:00,COVID-19s Impacts Demand on Medical Device Manufacturing Outsourcing Market 2020-2024 | Focus on Reducing Medical Device Manufacturing Cost to Boost Growth | Technavio,"Technavio has been monitoring the medical device manufacturing outsourcing market and it is poised to grow by USD 39.25 billion during 2020-2024, progressing at a CAGR of almost 11% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200918005222/en/ Technavio has announced its latest market research report titled Global Medical Device Manufacturing Outsourcing Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Request for Technavio's latest reports on directly and indirectly impacted markets. Market estimates include pre- and post-COVID-19 impact on the Medical Device Manufacturing Outsourcing Market Download free sample report The market is fragmented, and the degree of fragmentation will accelerate during the forecast period.",WST,en,Benzinga
2020-09-03 06:55:02-05:00,"The Daily Biotech Pulse: Sanofi, GSK Begin Phase 1/2 Coronavirus Vaccine Study, Fulgent Strikes COVID-19 Testing Deal, New Data From Novavax","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Avid Bioservices Inc (NASDAQ: CDMO ) ( reacted to strong quarterly results) BioLife Solutions Inc (NASDAQ: BLFS ) Corcept Therapeutics Incorporated (NASDAQ: CORT ) Edwards Lifesciences Corp (NYSE: EW ) Evogene Ltd (NASDAQ: EVGN ) Fortress Biotech (NASDAQ: FBIO ) Generation Bio Co (NASDAQ: GBIO ) Immunovant Inc (NASDAQ: IMVT ) (priced its 5.27-million-share common stock offering at $33 per share) Inspire Medical Systems Inc (NYSE: INSP ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Silk Road Medical Inc (NASDAQ: SILK ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) (announced potent SARS-CoV-2 neutralizing data from COVID-19 therapeutic antibody program) West Pharmaceutical Services Inc. (NYSE: WST ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 2) Acorda Therapeutics Inc (NASDAQ: ACOR ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) (priced a $9.6-million follow-on offering) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC ) Entera Bio Ltd (NASDAQ: ENTX ) Eyepoint Pharmaceuticals Inc (NASDAQ: EYPT ) Gritstone Oncology Inc (NASDAQ: GRTS ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Interpace Biosciences Inc (NASDAQ: IDXG ) Iterum Therapeutics PLC (NASDAQ: ITRM ) NanoVibronix Inc (NASDAQ: NAOV ) Neurobo Pharmaceuticals Inc (NASDAQ: NRBO ) Nkarta Inc (NASDAQ: NKTX ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Psychemedics Corp. (NASDAQ: PMD ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS ) Stocks In Focus Sutro To Present Positive Phase 1 Ovarian Cancer Data In an abstract submitted to the International Gynecologic Cancer Society …",WST,en,Benzinga
2020-09-02 06:25:11-05:00,"The Daily Biotech Pulse: Amarin's Vascepa Appeal Hearing, Avid Bioservices' Strong Q1, A Life Sciences Blank Check IPO","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) 10X Genomics Inc (NASDAQ: TXG ) Acutus Medical Inc (NASDAQ: AFIB ) Akouos Inc (NASDAQ: AKUS ) Catalent Inc (NYSE: CTLT ) Evogene Ltd (NASDAQ: EVGN ) (announced $10 million equity investment led by ARK Investment Management) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Pacific Biosciences of California Inc (NASDAQ: PACB ) PPD Inc (NASDAQ: PPD ) Shockwave Medical Inc (NASDAQ: SWAV ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Sept. 1) Acasti Pharma Inc (NASDAQ: ACST ) ADiTx Therapeutics Inc (NASDAQ: ADTX ) China SXT Pharmaceuticals Inc (NASDAQ: SXTC ) Entera Bio Ltd (NASDAQ: ENTX ) Freeline Therapeutics Holdings PLC (NASDAQ: FRLN ) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Histogen Inc (NASDAQ: HSTO ) Immatics NV (NASDAQ: IMTX ) NanoVibronix Inc (NASDAQ: NAOV ) Oncternal Therapeutics Inc (NASDAQ: ONCT ) Predictive Oncology Inc (NASDAQ: POAI ) Rockwell Medical Inc (NASDAQ: RMTI ) Sun BioPharma, Inc. (NASDAQ: SNBP ) Stocks In Focus Mesoblast Gets Ethics Approval For Using Stem Cell Therapy In COVID-19 Patients In Australia Mesoblast (NASDAQ: MESO ) said it has received ethics approval to include Australian hospitals in the Phase 3 randomized controlled trial of remestemcel-L in ventilator-dependent COVID-19 patients with acute respiratory distress syndrome.",WST,en,Benzinga
2020-07-23 07:25:53-05:00,"The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22) ABIOMED, Inc. (NASDAQ: ABMD ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) BioLife Solutions Inc (NASDAQ: BLFS ) CALLIDITAS THER/S ADR (NASDAQ: CALT ) Catalent Inc (NYSE: CTLT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Hologic, Inc. (NASDAQ: HOLX ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunic Inc (NASDAQ: IMUX ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) ( reported forecast-beating second-quarter results) Medpace Holdings Inc (NASDAQ: MEDP ) Novo Nordisk A/S (NYSE: NVO ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Otonomy Inc (NASDAQ: OTIC ) Penumbra Inc (NYSE: PEN ) Qiagen NV (NYSE: QGEN ) Quest Diagnostics Inc (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 22) Akouos Inc (NASDAQ: AKUS ) AnPac Bio-Medical Science Co Ltd – ADR (NASDAQ: ANPC ) Forma Therapeutics Holdings Inc (NASDAQ: FMTX ) Fusion Pharmaceuticals Inc (NASDAQ: FUSN ) Gritstone Oncology Inc (NASDAQ: GRTS ) Nkarta Inc (NASDAQ: NKTX ) RENALYTIX AI ADR (NASDAQ: RNLX ) (went public Friday) Tricida Inc (NASDAQ: TCDA ) Stocks In Focus Midatech Terminates Sale Process, Strategic Review to Continue Midatech Pharma PLC-ADR (NASDAQ: MTP ), a drug delivery technology company, said it has terminated the formal sale process initiated in late April after it failed to receive any proposals from third parties.",WST,en,Benzinga
2020-07-23 02:15:00-05:00,West Pharmaceutical Services: Q2 Earnings Insights,Shares of West Pharmaceutical Services (NYSE:WST) were flat in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per …,WST,en,Benzinga
2020-07-22 06:24:35-05:00,"The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat","Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) ABIOMED, Inc. (NASDAQ: ABMD ) Assembly Biosciences Inc (NASDAQ: ASMB ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Beigene Ltd (NASDAQ: BGNE ) BioLife Solutions Inc (NASDAQ: BLFS ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Catalent Inc (NYSE: CTLT ) CTI BioPharma Corp (NASDAQ: CTIC ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Heat Biologics Inc (NASDAQ: HTBX ) Hologic, Inc. (NASDAQ: HOLX ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intuitive Surgical, Inc. (NASDAQ: ISRG ) Ligand Pharmaceuticals Inc. (NASDAQ: LGND ) Natera Inc (NASDAQ: NTRA ) Novo Nordisk A/S (NYSE: NVO ) Opko Health Inc. (NASDAQ: OPK )(moved in reaction to an announcement it will offer COVID-19 diagnostics testing to the NFL) ResMed Inc. (NYSE: RMD ) Retrophin Inc (NASDAQ: RTRX ) Trevena Inc (NASDAQ: TRVN ) Twist Bioscience Corp (NASDAQ: TWST ) Veracyte Inc (NASDAQ: VCYT ) West Pharmaceutical Services Inc.",WST,en,Benzinga
2020-07-17 06:41:01-05:00,"The Daily Biotech Pulse: 2 IPOs, Nabriva Pneumonia Drug Gets Canadian Regulatory Nod, PhaseBio Doses First COVID-19 Trial Patient","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 16) AC Immune SA (NASDAQ: ACIU ) ( announced clinical trial update for its Alzheimer's vaccine candidate) argenx SE – ADR (NASDAQ: ARGX ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) Dynavax Technologies Corporation (NASDAQ: DVAX )(announced a collaboration with Mt. Sinai to develop a universal influenza vaccine candidate with CpG1018 adjuvant) Heat Biologics Inc (NASDAQ: HTBX ) Novavax, Inc. (NASDAQ: NVAX ) Qiagen NV (NYSE: QGEN )( Thermo Fisher Scientific Inc. (NYSE: TMO ) announced a sweetened offer to buy the company) Quest Diagnostics Inc (NYSE: DGX ) Otonomy Inc (NASDAQ: OTIC ) Principia Biopharma Inc (NASDAQ: PRNB )(reacted to buyout rumors) Relay Therapeutics Inc (NASDAQ: RLAY ) (jumped 75.25% on its debut) Sanofi SA (NASDAQ: SNY ) (Bloomberg reported the French biotech is on a lookout to buy biotech companies, including Principia) TIZIANA LF SCIE/S ADR (NASDAQ: TLSA ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 16) Avidity Biosciences Inc (NASDAQ: RNA ) Legend Biotech Corp (NASDAQ: LEGN ) Nkarta Inc (NASDAQ: NKTX ) (IPOed last Friday) Repare Therapeutics Inc (NASDAQ: RPTX ) Tricida Inc (NASDAQ: TCDA ) ( received a letter from FDA citing deficiencies in its NDA for the approval of metabolic …",WST,en,Benzinga Feeds
2020-07-16 07:31:22-05:00,"The Daily Biotech Pulse: Mallinckrodt Gets FDA Panel Backing, Regulatory Setback For Tricida, Relay Therapeutics IPO","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) Atossa Therapeutics Inc (NASDAQ: ATOS ) (announced results from lab studies of AT-301, its COVID-19 nasal spray drug candidate) AstraZeneca plc (NYSE: AZN ) (moved on reports that it could issue an update on its coronavirus vaccine program soon) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) Castle Biosciences Inc (NASDAQ: CSTL ) (announced publication of a study demonstrating its DecisionDx-UM test results significantly impacted treatment plan recommendations for patients with uveal melanoma) Catalent Inc (NYSE: CTLT ) Cytokinetics, Inc. (NASDAQ: CYTK ) (issued an investor update on its cardiovascular pipeline) ESSA Pharma Inc (NASDAQ: EPIX ) (announced enrollment of first patient in Phase 1 study of its prostate cancer drug) Genetic Technologies Limited (NASDAQ: GENE ) (issued an update on its COVID-19 Severity Risk Test) GENMAB A/S/S ADR (NASDAQ: GMAB ) Heat Biologics Inc (NASDAQ: HTBX ) Hologic, Inc.",WST,en,Benzinga
2020-07-14 07:04:55-05:00,"The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Altimmune Inc (NASDAQ: ALT ) (announced positive preclinical data for its intranasal vaccine candidate AdCOVID) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) (reacted to preliminary second-quarter results) Beigene Ltd (NASDAQ: BGNE ) - announced $421 million in additional investment by Amgen, Inc. (NASDAQ: AMGN ) in a $2.1-billion direct offering by the Chinese biotech BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) Catalent Inc (NYSE: CTLT ) DexCom, Inc. (NASDAQ: DXCM ) Equillium Inc (NASDAQ: EQ (announced positive results for COVID-19 study of the drug it is co-developing with India's Biocon) Fulgent Genetics Inc (NASDAQ: FLGT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Heat Biologics Inc (NASDAQ: HTBX ) Hologic, Inc.",WST,en,Benzinga
2020-07-10 06:25:13-05:00,"The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 9) Affimed NV (NASDAQ: AFMD ) Altimmune Inc (NASDAQ: ALT ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. (NYSE: BIOV ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCMV Dynavax Technologies Corporation (NASDAQ: DVAX ) Eli Lilly And Co (NYSE: LLY ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Horizon Therapeutics PLC (NASDAQ: HZNP ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Nantkwest Inc (NASDAQ: NK ) NeoGenomics, Inc. (NASDAQ: NEO ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Penumbra Inc (NYSE: PEN ) Qiagen NV ( NYSE: QGEN ) Quidel Corporation (NASDAQ: QDEL ) Regeneron Pharmaceuticals Inc (NASDAQ: REGN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) TG Therapeutics Inc (NASDAQ: TGTX ) Twist Bioscience Corp (NASDAQ: TWST ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows July 9) ANI Pharmaceuticals Inc (NASDAQ: ANIP ) Evolus Inc (NASDAQ: EOLS ) immatics biotechnologies GmbH (NASDAQ: IMTX ) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) ORIC Pharmaceuticals Inc (NASDAQ: ORIC ) Orchard Therapeutics PLC – ADR (NASDAQ: ORTX ) Polypid Ltd (NASDAQ: PYPD ) Recro Pharma Inc (NASDAQ: REPH ) Repare Therapeutics Inc (NASDAQ: RPTX ) Stocks In Focus Ziopharm Announces Initiation of Phase 1 Trial For Blood Cancer Cell Therapy ZIOPHARM Oncology Inc. (NASDAQ: ZIOP ) said it has initiated a phase 1 clinical trial to evaluate CD19-specific CAR-T, using its Rapid Personalized Manufacturing technology, or …",WST,en,Benzinga
2020-07-01 07:12:04-05:00,"The Daily Biotech Pulse: T2 Biosystems Launches COVID-19 Test, Akero Aces Midstage NASH Study, Aravive Added to Russell Indexes","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) ADC Therapeutics SA (NYSE: ADCT ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alterity Therapeutics Ltd (NASDAQ: ATHE ) ( announced agreement with the FDA regarding Phase 2 study of Parkinsonian disorder drug) Calliditas Therapeutics AB ADR (NASDAQ: CALT ) GENMAB A/S/S ADR (NASDAQ: GMAB ) - partner Seattle Genetics, Inc. (NASDAQ: SGEN ) announced positive results for antibody-drug conjugate for cervical cancer Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) ( reacted to a positive analyst action) Legend Biotech Corp (NASDAQ: LEGN ) Meridian Bioscience, Inc. (NASDAQ: VIVO ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Novavax, Inc. (NASDAQ: NVAX ) Opko Health Inc. (NASDAQ: OPK ) Pacira Biosciences Inc (NASDAQ: PCRX ) Pliant Therapeutics Inc (NASDAQ: PLRX ) ResMed Inc. (NYSE: RMD ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Twist Bioscience Corp (NASDAQ: TWST ) (announced launch of Twist Respiratory Virus Research Panel for detecting a range of respiratory diseases) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows June 30) Brickell Biotech Inc (NASDAQ: BBI ) Iterum Therapeutics PLC (NASDAQ: ITRM ) (announced $15 million registered offering) Qualigen Therapeutics Inc (NASDAQ: QLGN ) Sonnet Biotherapeutics Holdings Inc (NASDAQ: SONN ) VIVUS, Inc. (NASDAQ: VVUS ) Stocks In Focus T2 Biosystems Pre-Announces In-Line Q2 Revenues, Launches COVID-19 Test In US T2 Biosystems Inc (NASDAQ: TTOO ) announced the U.S. launch of the T2SARS-CoV-2 Panel, its COVID-19 molecular diagnostic test.",WST,en,Benzinga
2020-06-26 05:59:07-05:00,West Pharmaceutical Services : Performance of AccelTRA® Components | MarketScreener,"Performance of AccelTRA® Components To improve the consistent evaluation of the quality and efficacy of generic drugs for injections, National Medical… | June 26, 2020",WST,en,MarketScreener
2020-06-21 03:00:00-05:00,West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components,West Pharmaceutical Services to Host a Free Exclusive Webinar on Prefilled Syringe Elastomer Components taking place on 16th July 2020,WST,en,EIN News
2020-06-09 08:43:00-05:00,"Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge","Zacks.com featured highlights include: The Clorox Company, West Pharmaceutical Services and Everbridge",WST,en,Zacks Investment Research
2020-06-03 08:39:00-05:00,"Zacks.com featured highlights include: Synopsys, Tesla, Chemed, Teekay Tankers and West Pharmaceutical Services","Zacks.com featured highlights include: Synopsys, Tesla, Chemed, Teekay Tankers and West Pharmaceutical Services",WST,en,Zacks Investment Research
2020-06-02 23:24:00-05:00,"Samenvatting: Exosite geeft IoT-technologie licenties aan West Pharmaceutical Services, Inc.","MINNEAPOLIS--(BUSINESS WIRE)--West Pharmaceutical Services, Inc. licenses Exosite IoT technology to accelerate its digital transformation initiatives in the healthcare marketplace.",WST,en,Business Wire
2020-06-02 16:45:00-05:00,"Exosite octroie ses licences de technologie IdO à West Pharmaceutical Services, Inc.","MINNEAPOLIS--(BUSINESS WIRE)--Exosite LLC, un acteur de premier plan sur le marché de l’Internet des objets industriels (IdOI), a annoncé aujourd’hui qu’elle avait accordé l’utilisation sous licence de plusieurs de ses technologies et solutions logicielles à West Pharmaceutical Services, Inc. (NYSE : WST), un fournisseur mondial de solutions innovantes pour l’administration injectable de médicaments. West utilisera la technologie IdO d’Exosite pour soutenir et accélérer ses initiatives de trans",WST,fr,Business Wire
2020-06-02 15:46:00-05:00,"Exosite licencia tecnologia IoT para a West Pharmaceutical Services, Inc.","MINEÁPOLIS--(BUSINESS WIRE)--A Exosite LLC, fornecedora líder no mercado de Internet das Coisas Industriais (Industrial Internet of Things, IIoT), anunciou hoje que licenciou o uso de certas soluções e tecnologia de software para a West Pharmaceutical Services, Inc. (NYSE: WST), líder em soluções inovadoras para administração de drogas injetáveis. A West utilizará a tecnologia Internet das Coisas (IoT) da Exosite para apoiar e acelerar suas iniciativas de transformação digital. As duas organiza",WST,pt,Business Wire
2020-06-02 15:42:00-05:00,"Exosite lizenziert IoT-Technologie an West Pharmaceutical Services, Inc.","MINNEAPOLIS--(BUSINESS WIRE)--Exosite LLC, ein führender Anbieter auf dem Markt für das Industrielle Internet der Dinge (Industrial Internet of Things, IIoT), gab heute bekannt, dass sie die Nutzung bestimmter Softwaretechnologien und -lösungen an West Pharmaceutical Services, Inc. (NYSE: WST), einem weltweit führenden Unternehmen für innovative Lösungen für die Verabreichung von injizierbaren Medikamenten, lizenziert hat. West wird die IoT-Technologie von Exosite nutzen, um seine Initiativen z",WST,de,Business Wire
2020-06-02 12:33:00-05:00,"Exosite Autoriza la Tecnología de IoT a West Pharmaceutical Services, Inc.","MINNEAPOLIS--(BUSINESS WIRE)--Exosite LLC, proveedor líder en el mercado de Internet Industrial de las Cosas (Industrial Internet of Things, IIoT), anunció hoy que ha autorizado el uso de ciertas tecnologías y soluciones de software a West Pharmaceutical Services, Inc. (NYSE: WST), líder mundial en soluciones innovadoras para la administración de drogas inyectables. West utilizará la tecnología IoT de Exosite para respaldar y acelerar sus iniciativas de transformación digital. Las dos organizac",WST,es,Business Wire
2020-06-02 07:55:00-05:00,"Exosite Licenses IoT Technology to West Pharmaceutical Services, Inc.","MINNEAPOLIS--(BUSINESS WIRE)-- #IIoT--West Pharmaceutical Services, Inc. licenses Exosite IoT technology to accelerate its digital transformation initiatives in the healthcare marketplace.",WST,en,Business Wire
2020-06-01 08:41:00-05:00,"Zacks.com featured highlights include: West Pharmaceutical Services, Teradyne, Dollar General, Applied Materials and Kroger","Zacks.com featured highlights include: West Pharmaceutical Services, Teradyne, Dollar General, Applied Materials and Kroger",WST,en,Zacks Investment Research
2020-05-19 07:43:00-05:00,"Zacks.com featured highlights include: NextEra Energy, Kinsale Capital Group, Vectrus, Teekay Tankers and West Pharmaceutical Services","Zacks.com featured highlights include: NextEra Energy, Kinsale Capital Group, Vectrus, Teekay Tankers and West Pharmaceutical Services",WST,en,Zacks Investment Research
2020-05-19 07:24:15-05:00,"The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering","Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18) ADC Therapeutics SA (NYSE: ADCT ) (went public May 15) Allogene Therapeutics Inc (NASDAQ: ALLO ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) AtriCure Inc. (NASDAQ: ATRC ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Evoke Pharma Inc (NASDAQ: EVOK ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Geron Corporation (NASDAQ: GERN ) Horizon Therapeutics PLC (NASDAQ: HZNP ) I-Mab ADR (NASDAQ: IMAB ) Immunomedics, Inc. (NASDAQ: IMMU ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) Mersana Therapeutics Inc (NASDAQ: MRSN ) Minerva Neurosciences Inc (NASDAQ: NERV ) Moderna Inc (NASDAQ: MRNA ) ( announced positive interim Phase 1 readout for coronavirus vaccine) Myokardia Inc (NASDAQ: MYOK ) Neurocrine Biosciences, Inc. (NASDAQ: NBIX ) Novavax, Inc. (NASDAQ: NVAX ) (reacted to upward price target adjustment by B.",WST,en,Benzinga
2020-05-13 06:40:30-05:00,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) Acceleron Pharma Inc (NASDAQ: XLRN )(reacted to its first-quarter results) Allogene Therapeutics Inc (NASDAQ: ALLO ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Arvinas Inc (NASDAQ: ARVN ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) BioSig Technologies Inc (NASDAQ: BSGM ) BIO-TECHNE Corp (NASDAQ: TECH ) BioXcel Therapeutics Inc (NASDAQ: BTAI )(announced its first-quarter results) Black Diamond Therapeutics Inc (NASDAQ: BDTX )(reacted to its first-quarter results) ChemoCentryx Inc (NASDAQ: CCXI )(reacted to its first-quarter results) Cytokinetics, Inc. (NASDAQ: CYTK ) CytomX Therapeutics Inc (NASDAQ: CTMX ) Cytosorbents Corp (NASDAQ: CTSO )(announced European approval for Cytosorb) Emergent Biosolutions Inc (NYSE: EBS ) Exelixis, Inc. (NASDAQ: EXEL ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Halozyme Therapeutics, Inc.","XLRN,WST",en,Benzinga
2020-04-30 12:14:00-05:00,Will West Pharmaceutical Services Continue to Surge Higher?,"As of late, it has definitely been a great time to be an investor West Pharmaceutical Services",WST,en,Zacks Investment Research
2020-04-28 07:48:00-05:00,"Zacks.com featured highlights include: General Mills, Dollar General, West Pharmaceutical Services, Atlas Air Worldwide and CoreLogic","Zacks.com featured highlights include: General Mills, Dollar General, West Pharmaceutical Services, Atlas Air Worldwide and CoreLogic",WST,en,Zacks Investment Research
2020-04-28 06:36:28-05:00,"The Daily Biotech Pulse: Pfizer Earnings, Roche's Spinal Muscular Dystrophy Treatment, Moderna COVID-19 Vaccine Update","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) AstraZeneca plc (NYSE: AZN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Arcturus Therapeutics Ltd (NASDAQ: ARCT ) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) BioMarin Pharmaceutical Inc. (NASDAQ: BMRN ) Bio-Rad Laboratories, Inc. (NYSE: BIO ) BioSig Technologies Inc (NASDAQ: BSGM ) Black Diamond Therapeutics Inc (NASDAQ: BDTX ) Cytosorbents Corp (NASDAQ: CTSO ) DexCom, Inc. (NASDAQ: DXCM ) Erytech Pharma SA (NASDAQ: ERYP ) Exelixis, Inc. (NASDAQ: EXEL ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) I-Mab ADR (NASDAQ: IMAB ) Imara Inc (NASDAQ: IMRA ) Incyte Corporation (NASDAQ: INCY ) Kala Pharmaceuticals Inc (NASDAQ: KALA ) Keros Therapeutics Inc (NASDAQ: KROS ) Masimo Corporation (NASDAQ: MASI ) Novo Nordisk A/S (NYSE: NVO ) OraSure Technologies, Inc. (NASDAQ: OSUR ) Quidel Corporation (NASDAQ: QDEL ) REDHILL BIOPHAR/S ADR (NASDAQ: RDHL ) Repligen Corporation (NASDAQ: RGEN ) Seattle Genetics, Inc. (NASDAQ: SGEN ) Translate Bio Inc (NASDAQ: TBIO ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) Vaxart Inc (NASDAQ: VXRT ) Vermillion, Inc. (NASDAQ: VRML ) West Pharmaceutical Services Inc. (NYSE: WST ) Y-mAbs Therapeutics, Inc (NASDAQ: YMAB ) Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL ) Zynex Inc. (NASDAQ: ZYXI ) None of the Nasdaq- or NYSE-listed biotech/medical device/diagnostics company hit 52-week lows Monday.",WST,en,Benzinga
2020-04-23 14:08:02-05:00,Why West Pharmaceutical Stock Is Trading Higher Today,West Pharmaceutical Services Inc. (NYSE: WST ) shares were trading higher Thursday … Full story available on Benzinga.com,WST,en,Benzinga Feeds
2020-04-23 06:30:08-05:00,West Pharmaceutical Services (WST) Q1 Earnings and Revenues Beat Estimates,"West Pharmaceutical (WST) delivered earnings and revenue surprises of 23.17% and 5.39%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?",WST,en,Zacks Investment Research
2020-04-20 05:00:00-05:00,West to Host Virtual Shareholders Meeting,"EXTON, Pa., April 20, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to the ongoing…",WST,en,PR Newswire
2020-04-13 14:03:03-05:00,West Pharmaceutical Services : Revised Drug Administration Law of the People's Republic of China | MarketScreener,"Revised Drug Administration Law of the People's Republic of China The Standing Committee of the National People's Congress in China passed the revised Drug… | April 13, 2020",WST,en,MarketScreener
2020-04-10 11:10:09-05:00,Can West Pharmaceutical (WST) Keep the Earnings Surprise Streak Alive?,West Pharmaceutical (WST) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.,WST,en,Zacks Investment Research
2020-02-25 06:01:26-05:00,West Pharmaceutical Services : Announces Second-Quarter Dividend | MarketScreener,"EXTON, Pa., Feb. 25, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. , a global leader in innovative solutions for injectable drug administration, announced today that the Company's… | February 25, 2020",WST,en,MarketScreener
2020-02-14 08:23:03-05:00,"The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering","The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL ) AtriCure Inc. (NASDAQ: ATRC ) Beam Therapeutics Inc (NASDAQ: BEAM ) BioXcel Therapeutics Inc (NASDAQ: BTAI ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) Insulet Corporation (NASDAQ: PODD ) Krystal Biotech Inc (NASDAQ: KRYS ) Masimo Corporation (NASDAQ: MASI ) NeoGenomics, Inc. (NASDAQ: NEO ) Nevro Corp (NYSE: NVRO ) Recro Pharma Inc (NASDAQ: REPH ) ResMed Inc. (NYSE: RMD ) Revolution Medicines Inc (NASDAQ: RVMD ) (went public Thursday) Syneos Health Inc (NASDAQ: SYNH ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) Taro Pharmaceutical Industries Ltd. (NYSE: TARO ) West Pharmaceutical Services Inc.",WST,en,Benzinga Feeds
2020-02-13 08:05:12-05:00,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 12) AbbVie Inc (NYSE: ABBV ) Agile Therapeutics Inc (NASDAQ: AGRX ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Allergan plc (NYSE: AGN ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Aptose Biosciences Inc (NASDAQ: APTO ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) Avrobio Inc (NASDAQ: AVRO ) Beam Therapeutics Inc (NASDAQ: BEAM ) Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI ) ChemoCentryx Inc (NASDAQ: CCXI ) Cytokinetics, Inc. (NASDAQ: CYTK ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fate Therapeutics Inc (NASDAQ: FATE ) ITAMAR MED LTD/S ADR (NASDAQ: ITMR ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) NeoGenomics, Inc. (NASDAQ: NEO ) Novartis AG (NYSE: NVS ) Ocular Therapeutix Inc (NASDAQ: OCUL ) PAVmed Inc (NASDAQ: PAVM ) Penumbra Inc (NYSE: PEN ) Prevail Therapeutics Inc (NASDAQ: PRVL )(reacted to the FDA according Orphan Drug Designation to its experimental gene therapy PR001 for treating Gaucher disease) PTC Therapeutics, Inc (NASDAQ: PTCT ) Repligen Corporation (NASDAQ: RGEN ) Tandem Diabetes Care Inc (NASDAQ: TNDM ) West Pharmaceutical Services Inc.",WST,en,Benzinga
2020-02-13 06:00:00-05:00,West Announces Fourth-Quarter and Full-Year 2019 Results,"EXTON, Pa., Feb. 13, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance. Fourth-Quarter and Full-Year 2019 Summary (comparisons to prior-year…",WST,en,PR Newswire
2020-02-12 09:18:32-05:00,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 11) AbbVie Inc (NYSE: ABBV ) Acceleron Pharma Inc (NASDAQ: XLRN ) Agile Therapeutics Inc (NASDAQ: AGRX )( announced securing of loan facility) Allergan plc (NYSE: AGN ) Akebia Therapeutics Inc (NASDAQ: AKBA ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Ascendis Pharma A/S (NASDAQ: ASND ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) ChemoCentryx Inc (NASDAQ: CCXI ) Cue Biopharma Inc (NASDAQ: CUE ) Cytokinetics, Inc. (NASDAQ: CYTK ) Deciphera Pharmaceuticals Inc (NASDAQ: DCPH ) DexCom, Inc. (NASDAQ: DXCM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fulgent Genetics Inc (NASDAQ: FLGT ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Insulet Corporation (NASDAQ: PODD ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Nevro Corp (NYSE: NVRO ) Novartis AG (NYSE: NVS )(announced priority review for its lung cancer drug) Pacira Biosciences Inc (NASDAQ: PCRX ) PAVmed Inc (NASDAQ: PAVM )(PAVmed's EsoGuard Esophageal DNA test was accorded Breakthrough Device designation) Penumbra Inc (NYSE: PEN ) Principia Biopharma Inc (NASDAQ: PRNB ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Seattle Genetics, Inc. (NASDAQ: SGEN )(announced positive data readout for ADC in bladder cancer) Syneos Health Inc (NASDAQ: SYNH ) Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX ) West Pharmaceutical Services Inc. (NYSE: WST ) Zai Lab Ltd (NASDAQ: ZLAB ) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Feb. 11) ADDEX THERAPEUT/ADR (NASDAQ: ADXN ) Brickell Biotech Inc (NASDAQ: BBI ) Endologix, Inc. (NASDAQ: ELGX ) Enzo Biochem, Inc. (NYSE: ENZ )( received New York State approval for its gynecological …",WST,en,Benzinga
2020-02-05 07:43:12-05:00,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Feb. 4) Acceleron Pharma Inc (NASDAQ: XLRN ) Alector Inc (NASDAQ: ALEC ) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) Applied Therapeutics Inc (NASDAQ: APLT ) Aptose Biosciences Inc (NASDAQ: APTO ) Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT )(IPOed Jan. 31) Black Diamond Therapeutics Inc (NASDAQ: BDTX )(IPOed Jan. 30) ChemoCentryx Inc (NASDAQ: CCXI ) Eli Lilly And Co (NYSE: LLY ) Fate Therapeutics Inc (NASDAQ: FATE ) Frequency Therapeutics Inc (NASDAQ: FREQ ) GALAPAGOS NV/S ADR (NASDAQ: GLPG ) Hologic, Inc. (NASDAQ: HOLX ) Insmed Incorporated (NASDAQ: INSM )(reacted to positive analyst actions following a positive data readout reported Monday) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ ) Masimo Corporation (NASDAQ: MASI ) Medpace Holdings Inc (NASDAQ: MEDP ) Molecular Templates Inc (NASDAQ: MTEM ) Neoleukin Therapeutics Inc (NASDAQ: NLTX ) PTC Therapeutics, Inc (NASDAQ: PTCT ) Quest Diagnostics Inc (NYSE: DGX ) Reata Pharmaceuticals Inc (NASDAQ: RETA ) Repligen Corporation (NASDAQ: RGEN ) ResMed Inc.",WST,en,Benzinga
2020-02-05 05:00:00-05:00,West Launches New Product Innovations at Pharmapack 2020,"EXTON, Pa., Feb. 5, 2020 /PRNewswire/ -- (Booth #B58) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce several new, innovative pharmaceutical containment and closure offerings…",WST,en,PR Newswire
2020-01-30 09:26:49-05:00,"The Daily Biotech Pulse: Sanofi Reports Positive Readout, Tonix Vaccine Candidate Aces Animal Study, Hologix's Weak Guidance","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 29) 10X Genomics Inc (NASDAQ: TXG ) Agile Therapeutics Inc (NASDAQ: AGRX ) Aptose Biosciences Inc (NASDAQ: APTO ) Catalent Inc (NYSE: CTLT ) Cabaletta Bio Inc (NASDAQ: CABA )(announced grant of orphan drug designation for its DSG3-CAART for the treatment of pemphigus vulgaris) AtriCure Inc. (NASDAQ: ATRC ) Dr.Reddy's Laboratories Ltd (NYSE: RDY ) Fate Therapeutics Inc (NASDAQ: FATE ) Hologic, Inc. (NASDAQ: HOLX ) Insulet Corporation (NASDAQ: PODD ) Johnson & Johnson (NYSE: JNJ )(confirmed it is working on treatment/vaccines for coronavirus) Nevro Corp (NYSE: NVRO ) Profound Medical Corp (NASDAQ: PROF ) Quest Diagnostics Inc (NYSE: DGX ) ResMed Inc. (NYSE: RMD ) Satsuma Pharmaceuticals Inc (NASDAQ: STSA )(reacted to publication of positive data readout for its lead drug candidate) Tandem Diabetes Care Inc (NASDAQ: TNDM ) West Pharmaceutical Services Inc. (NYSE: WST ) Zimmer Biomet Holdings Inc (NYSE: ZBH ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 29) Avanos Medical Inc (NYSE: AVNS ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Endologix, Inc. (NASDAQ: ELGX ) Galectin Therapeutics Inc.",WST,en,Benzinga
2020-01-30 06:00:00-05:00,West to Host Fourth-Quarter and Full-Year 2019 Conference Call,"EXTON, Pa., Jan. 30, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2019 financial results before the market opens on…",WST,en,PR Newswire
2020-01-28 08:00:00-05:00,West Recognized as a Top Company for Corporate Responsibility,"EXTON, Pa., Jan. 28, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, was recently named as a Top Company for Corporate Responsibility practices by both Newsweek and Investor's Business Daily….",WST,en,PR Newswire
2020-01-15 08:22:46-05:00,"The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance","The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ): announced an oncology stem cell therapy pact with Astellas Pharma Inc. (OTC: ALPMY ). Applied Therapeutics Inc (NASDAQ: APLT ) Arvinas Inc (NASDAQ: ARVN ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Calithera Biosciences Inc (NASDAQ: CALA ) Editas Medicine Inc (NASDAQ: EDIT ) Eli Lilly And Co (NYSE: LLY ) Epizyme Inc (NASDAQ: EPZM ) Fate Therapeutics Inc (NASDAQ: FATE ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (provided 2020 guidance) Hologic, Inc. (NASDAQ: HOLX ) Medpace Holdings Inc (NASDAQ: MEDP ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novo Nordisk A/S (NYSE: NVO ) NuVasive, Inc. (NASDAQ: NUVA ) Profound Medical Corp (NASDAQ: PROF ) Repligen Corporation (NASDAQ: RGEN ) Replimune Group Inc (NASDAQ: REPL ) Revance Therapeutics Inc (NASDAQ: RVNC ) Syneos Health, Inc. (NASDAQ: SYNH ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Varian Medical Systems, Inc. (NYSE: VAR ) Viela Bio Inc (NASDAQ: VIE ) West Pharmaceutical Services Inc. (NYSE: WST ) XBiotech Inc (NASDAQ: XBIT ) (announced a tender offer to buy up to $420 million worth …","XBIT,WST",en,Benzinga
2020-01-03 07:55:22-05:00,"The Daily Biotech Pulse: Acorda Surges As Point72 Hikes Stake, Novan Sinks On Failed Study, Illumina-Pac Bio Terminate Merger","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 2) Agile Therapeutics Inc (NASDAQ: AGRX (announced the appointment of healthcare industry veteran Kimberly Whelan as VP, Market Access, as it prepares for a potential Twirla commercial launch) Aimmune Therapeutics Inc (NASDAQ: AIMT ) Applied Therapeutics Inc (NASDAQ: APLT ) Ascendis Pharma A/S (NASDAQ: ASND ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Cassava Sciences Inc (NASDAQ: SAVA ) ChemoCentryx Inc (NASDAQ: CCXI ) DBV TECHNOLOGIE/S ADR (NASDAQ: DBVT ) Epizyme Inc (NASDAQ: EPZM ) Esperion Therapeutics Inc (NASDAQ: ESPR ) Fortress Biotech (NASDAQ: FBIO ) INNATE PHARMA S/S ADR (NASDAQ: IPHA )( announced EMA acceptance of regulatory application for drug to treat hairy cell leukemia) The Medicines Company (NASDAQ: MDCO ) Mesoblast limited (NASDAQ: MESO )(announced submission of safety and efficacy data as part of rolling BLA submission for remestemcell-L for the treatment of children with steroid-refractory acute graft versus host disease) Mirati Therapeutics Inc (NASDAQ: MRTX ) Nevro Corp (NYSE: NVRO ) NuVasive, Inc. (NASDAQ: NUVA ) Otonomy Inc (NASDAQ: OTIC ) Syneos Health Inc (NASDAQ: SYNH ) Urovant Sciences Ltd (NASDAQ: UROV ) Veru Inc (NASDAQ: VERU ) West Pharmaceutical Services Inc. (NYSE: WST ) Zoetis Inc (NYSE: ZTS ) Down In The Dumps (Biotech stocks hitting 52-week lows on Jan. 2) Alterity Therapeutics Ltd (NASDAQ: ATHE ) Evelo Biosciences Inc (NASDAQ: EVLO ) Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI ) Stealth BioTherapeutics Corp (NASDAQ: MITO ) Wave Life Sciences Ltd (NASDAQ: WVE ) Xeris Pharmaceuticals Inc (NASDAQ: XERS ) Stocks In Focus Acorda Gains After Hedge Fund Hikes Stake Acorda Therapeutics …","WST,XERS",en,Benzinga
2019-12-09 11:51:00-05:00,Global Pharmaceutical Analytical Testing Services Market Procurement Intelligence Report 2019 - ResearchAndMarkets.com,"DUBLIN--(BUSINESS WIRE)--The ""Global Pharmaceutical Analytical Testing Services Market - Procurement Intelligence Report"" report has been added to ResearchAndMarkets.com's offering. The report recognizes the following companies as the key suppliers in the market - Eurofins GSC Lux Sarl, SGS SA, Charles River Laboratories International Inc, WuXi AppTec Inc, Intertek Group Plc, West Pharmaceutical Services Inc. According to the report, one of the key growth contributors for the global pharmaceuti",WST,en,Business Wire
2019-11-06 05:00:00-05:00,West and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West's Ready Pack™ System,"FRANKFURT, Germany , Nov. 6, 2019 /PRNewswire/ -- (Booths #F62 & #F10 -Hall 11.1 ) West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, and the international technology group SCHOTT, a leading primary packaging solutions provider, today announced a partnership to combine the SCHOTT iQ® platform with West's Ready Pack™ system. The collaboration will initially launch by combining West components and SCHOTT's adaptiQ® high-quality RTU glass vials and will expand to include other convenient, ready-to-use combinations of West and SCHOTT products, to be available on a small-quantity basis. The companies made the announcement at the CPhI Worldwide conference, and shared plans to expand West's Ready Pack system to include additional SCHOTT glass offerings— including more vial formats as well as ready-to-use cartridges (cartriQ™) and pre-fillable glass syringes (syriQ®). Further product launch plans will be shared at the Pharmapack meeting in early 2020. ""With more than 4,000 new injectable drug products in development worldwide, many of which are in small settings such as universities, medical research institutes, or smaller-sized companies, West appreciates and understands the need to provide ready-to-use, high quality, sterile packaging products in small volumes for developmental and clinical phases,"" said Mike Schaefers , Ph.D., Vice President and General Manager, Pharma, West. ""Our partnership with SCHOTT now provides our customers with high-quality glass containment options to complement the stoppers, seals and glass alternatives West already provides through its Ready Pack system."" ""Easy and fast access to our broad product portfolio of ready-to-use vials and components not only gives flexibility in the drug development and production process, but also helps to enhance patient's safety as an overall target,"" said Fabian Stöcker, VP, Global Strategy and Innovation, SCHOTT Pharmaceutical Systems.",WST,en,Benzinga Feeds
2019-11-01 08:13:29-05:00,West Pharmaceutical Services : Cornell Program Leads to the Development of a Programmable Drug Delivery System | MarketScreener,"West-Cornell Program Leads to the Development of a Programmable Drug Delivery System A team of three Cornell University Biomedical Engineering graduate students recently… | November 1, 2019",WST,en,MarketScreener
2019-10-25 00:24:24-05:00,West Pharmaceutical Services (WST) Q3 2019 Earnings Call Transcript | The Motley Fool,"WST earnings call for the period ending September 30, 2019.",WST,en,The Motley Fool
2019-10-24 06:30:15-05:00,West Pharmaceutical Services (WST) Q3 Earnings and Revenues Top Estimates,"West Pharmaceutical (WST) delivered earnings and revenue surprises of 11.27% and 0.81%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?",WST,en,Zacks Investment Research
2019-10-20 14:01:07-05:00,Hedge Funds Have Never Been This Bullish On West Pharmaceutical Services Inc. (WST),A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers,WST,en,ACI Information Group
2019-10-17 09:33:27-05:00,Analysts Estimate West Pharmaceutical Services (WST) to Report a Decline in Earnings: What to Look Out for,West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.,WST,en,Zacks Investment Research
2019-09-06 06:27:25-05:00,"The Daily Biotech Pulse: European Nod For Roche, Takeda Recall, Neon Exults On Journal Publication","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Sept. 5) Bioanalytical Systems, Inc. (NASDAQ: BASI ) NextCure Inc (NASDAQ: NXTC ) Pfenex Inc (NYSE: PFNX ) Protagonist Therapeutics Inc (NASDAQ: PTGX ) ResMed Inc. (NYSE: RMD ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Sept. 5) Adamis Pharmaceuticals Corp (NASDAQ: ADMP ) BioNano Genomics Inc (NASDAQ: BNGO ) Endologix, Inc. (NASDAQ: ELGX ) Mallinckrodt PLC (NYSE: MNK ) ( retreated amid reports of restructuring ahead of Cleveland opioid litigation) Merit Medical Systems, Inc. (NASDAQ: MMSI ) VBI Vaccines Inc (NASDAQ: VBIV ) Zafgen Inc (NASDAQ: ZFGN ) ( announced decision to explore strategic options) See Also: Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day Stocks In Focus Neon's Process To Predict Neoantigens To Control Tumor Growth Published In Scientific Journal Neon Therapeutics Inc (NASDAQ: NTGN ) announced publication in the scientific journal ""Immunity,"" a breakthrough process for predicting which neoantigens will be presented by MHC Class II molecules in the tumor microenvironment.",WST,en,Benzinga
2019-09-05 08:35:07-05:00,West Pharmaceutical (WST) Hits Fresh High: Is There Still Room to Run?,"West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",WST,en,Zacks Investment Research
2019-08-08 08:25:05-05:00,"West Pharmaceutical (WST) Hits 52-Week High, Can the Run Continue?","West Pharmaceutical (WST) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.",WST,en,Zacks Investment Research
2019-08-08 06:11:00-05:00,"The Daily Biotech Pulse: Glaukos To Buy Avedro, Mixed Adcom Vote For Gilead, Dynavax Offering","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Aug. 7) Akero Therapeutics Inc (NASDAQ: AKRO ) Allakos Inc (NASDAQ: ALLK ) Cytokinetics, Inc. (NASDAQ: CYTK ) Guardant Health Inc (NASDAQ: GH ) (reacted to strong second-quarter results) Morphic Holding Inc (NASDAQ: MORF ) West Pharmaceutical Services Inc. (NYSE: WST ) Down In The Dumps (Biotech stocks hitting 52-week lows on Aug. 7) ABIOMED, Inc. (NASDAQ: ABMD ) Assertio Therapeutics Inc (NASDAQ: ASRT ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Bicycle Therapeutics PLC (NASDAQ: BCYC ) BioCardia Inc (NASDAQ: BCDA ) BIOLINERX LTD/S ADR (NASDAQ: BLRX ) Biopharmx Corp NYSE: (BPMX) CAN-FITE BIOPHA/S ADR (NYSE: CANF ) CELLECT BIOTECH/S ADR (NASDAQ: APOP ) Cellular Biomedicine Group Inc (NASDAQ: CBMG )(reacted to second-quarter results) Eloxx Pharmaceuticals Inc (NASDAQ: ELOX )(reported second-quarter results) Guardion Health Sciences Inc (NASDAQ: GHSI )(announced common stock offering of 9.",WST,en,Benzinga
2019-07-26 06:26:37-05:00,"The Daily Biotech Pulse: Obseva Gets The Greenlight, Verastem Climbs On Licensing Deal, Merit Medical Earnings Disappoint","Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on July 25) Akero Therapeutics Inc (NASDAQ: AKRO ) Anika Therapeutics Inc (NASDAQ: ANIK )( reported better-than-expected second-quarter results) Novocure Ltd (NASDAQ: NVCR )(reported strong second-quarter results) Repligen Corporation (NASDAQ: RGEN ) Xenetic Biosciences Inc (NASDAQ: XBIO ) Baxter International Inc (NYSE: BAX ) (reacted to strong second-quarter results) West Pharmaceutical Services Inc. (NYSE: WST ) (reacted to strong second-quarter results) Myovant Sciences Ltd (NYSE: MYOV ) Down In The Dumps (Biotech stocks hitting 52-week lows on July 25) Abeona Therapeutics Inc (NASDAQ: ABEO )(announced results from a Phase 1/2 trial of its ABO-102, its gene therapy candidate for San Filippo syndrome Type A) Aclaris Therapeutics Inc (NASDAQ: ACRS ) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP )(announced initiation of trial dubbed SPEARHEAD-1 that is evaluating ADP-A2M4 SPEAR T cells for patients with synovial sarcoma or myxoid/round cell liposarcoma) Aduro BioTech Inc (NASDAQ: ADRO ) Alkermes Plc (NASDAQ: ALKS )(reacted to Q2 results) Alterity Therapeutics Ltd (NASDAQ: ATHE ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) ANCHIANO THERAP/S ADR (NASDAQ: ANCN ) Aquestive Therapeutics Inc (NASDAQ: AQST ) Assembly Biosciences Inc (NASDAQ: ASMB ) Atara Biotherapeutics Inc (NASDAQ: ATRA ) BENITEC BIOPHAR/S ADR (NASDAQ: BNTC ) ChemoCentryx Inc (NASDAQ: CCXI ) Dynavax Technologies Corporation (NASDAQ: DVAX ) Foamix Pharmaceuticals Ltd (NASDAQ: FOMX ) Gamida Cell Ltd (NASDAQ: GMDA ) GENFIT S A/ADR (NASDAQ: GNFT ) Innoviva Inc (NASDAQ: INVA )(reported below-consensus second-quarter results) Intercept Pharmaceuticals Inc (NASDAQ: ICPT ) Kaleido Biosciences Inc (NASDAQ: KLDO ) Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA ) Neon Therapeutics Inc (NASDAQ: …",WST,en,Benzinga
2019-07-25 06:30:15-05:00,West Pharmaceutical Services (WST) Beats Q2 Earnings and Revenue Estimates,"West Pharmaceutical (WST) delivered earnings and revenue surprises of 23.61% and 1.68%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?",WST,en,Zacks Investment Research
2019-05-08 05:37:47-05:00,West Pharmaceutical declares $0.15 dividend,No summary available.,WST,en,Seeking Alpha
2019-04-26 01:29:26-05:00,West Pharmaceutical Services (WST) Q1 2019 Earnings Call Transcript,"WST earnings call for the period ending March 31, 2019.",WST,en,The Motley Fool
2019-04-25 22:38:21-05:00,"West Pharmaceutical Services, Inc. (WST) CEO Eric Green on Q1 2019 Results - Earnings Call Transcript",No summary available.,WST,en,Seeking Alpha
2019-04-25 08:52:16-05:00,"West Pharmaceutical Services, Inc. 2019 Q1 - Results - Earnings Call Slides","The following slide deck was published by West Pharmaceutical Services, Inc. in conjunction with their 2019 Q1 earnings call.",WST,en,Seeking Alpha
2019-04-25 05:01:49-05:00,"West Pharmaceutical beats by $0.08, beats on revenue",No summary available.,WST,en,Seeking Alpha
2019-02-14 15:24:05-05:00,West Pharmaceutical Services' (WST) CEO Eric Green on Q4 2018 Results - Earnings Call Transcript,"West Pharmaceutical Services, Inc. (NYSE:WST) Q4 2018 Earnings Conference Call February 14, 2019 9:00 AM ET Company Participants Quintin Lai – Vice President of",WST,en,Seeking Alpha
